Brief: Lytix Biopharma Q1 Loss Before Tax Narrows To NOK 18.2 Million

Lytix Biopharma AS

30/05/2024 06:21

May 30 (Reuters) - Lytix Biopharma AS  LYTIX.OL :
    * DURING Q1 LYTIX GENERATED A REVENUE OF NOK 10.5 MILLION
FOR SALE
OF LTX-315 TO VERRICA FOR USE IN THEIR CLINICAL TRIAL
    * Q1 LOSS BEFORE TAX NOK 18.2 MILLION VERSUS NOK 19.7
MILLION YEAR
AGO

Source text for Eikon:  ID:nObijg3wVa 
Further company coverage:  LYTIX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))